Molecular biomarkers consent to apply individual decisions in the complex management of both acute or chronic diseases, and their identification constitutes a fundamental phase for achieving the important object to develop personalized therapies [...].
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495828 | PMC |
http://dx.doi.org/10.3390/antiox11091766 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!